Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Women Diagnosed With Cancer 1Urinary Bladder Neoplasms 1Polycystic Ovary Syndrome 1Neoplasms 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1

Interventions

Metformin 149Clomiphene 51Letrozole 39Inositol 35Folic Acid 18Exercise 17Progesterone 15Ethinyl Estradiol 13Chorionic Gonadotropin 13Caloric Restriction 13drospirenone and ethinyl estradiol combination 12Estradiol 12Contraceptives, Oral 11cetrorelix 10Pioglitazone 10High-Intensity Interval Training 10Tablets 9Spironolactone 9Cholecalciferol 9Triptorelin Pamoate 8Diet 8Vitamin D 7Thioctic Acid 7Menotropins 7Liraglutide 7Acupuncture Therapy 7drospirenone 6Ovidrel 6Gonadotropins 6Flutamide 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Polycystic Ovary Syndrome × Cryopreservation × Clear all
NCT05112692 2021-11-09

Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles

Mansoura University

Phase NA Unknown
200 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡